Introduction {#S1}
============

During past decades, lipid molecules present in the CNS were considered components of cell membranes and organelles, intermediary metabolites, or constituents of the energy reservoirs. Currently, it is known that neurolipids are bioactive molecules that can act as neurotransmitters with neuromodulatory properties. Studies analyzing lipid molecules related to signaling systems are clarifying the complex integration of different lipid-metabolic pathways with other physiological functions mediated by lipids. The involvement of lipids in physiological and pathological processes can now also be analyzed by the development of new and potent analytical tools and instruments that enable rapid, high-throughput lipidomic analyses of rodent and human brain tissue sections at anatomical resolution, such as IMS ([@B24]; [@B43]).

Lipid mediators, synthesized from glycerophospholipids, are a class of bioactive lipids that are produced locally through specific biosynthetic pathways in response to extracellular stimuli. These lipid molecules, which hereafter we will call neurolipids, mediate neurotransmission as important endogenous regulators of multiple cerebral processes related to neuroprotective actions, such as neural cell proliferation, differentiation, response to oxidative stress, inflammation and apoptosis. Neurolipids are transported to extracellular compartments (by non-well-defined mechanisms), usually bind to specific GPCRs to trigger intracellular signaling and responses in target cells, and then are sequestered rapidly through enzymatic or non-enzymatic processes ([@B49]). Representative members of this class of neurolipids are eCBs and the LP, LPA.

The first CB receptor cDNA was cloned in 1990 as the first GPCR for lipid mediators ([@B45]). Two CB subtypes have been cloned: CB~1~, the most abundant CB receptor subtype in the CNS, and CB~2~, which is more restricted to glial cells. However, the CB~2~ receptor appears to be expressed by some neurons, particularly under certain pathological conditions ([@B67]; [@B69]; [@B22]; [@B51]). Moreover, there is evidence for other possible G protein-coupled CBs in the brain ([@B31]; [@B17]; [@B9]). Concerning the other above-mentioned LPs, the first high-affinity cognate cell surface receptor for LPA that was identified as the most abundant in the CNS was LPA~1~, but two additional receptors have been identified (LPA~2~ and LPA~3~). More recently, another three LPA receptors were identified, which were somewhat divergent receptors (LPA~4~, LPA~5~, LPA~6~) (reviewed in [@B12]; [@B72]). These two families of GPCRs, the CB and the LPA GPCRs, are phylogenetically related. CBs share 18--20% identity of the amino acid sequence with LPA receptors, in particular with LPA~1~, LPA~2~, and LPA~3~ ([@B14]).

Both LPA and eCBs are synthesized mainly by the cleavage of phospholipids (PLs), probably at the cell membrane. The distribution pattern of CB~1~ and CB~2~ receptors in the developing and adult brain is highly correlated with the expression of the DAGLα/β enzymes, responsible for 2-AG synthesis, suggesting that PL precursors would also be closely localized ([@B8]; [@B71]; [@B53]). However, little is known about the specific lipid species that constitute the eCB precursors and particularly, about their specific localization in the brain ([@B39]). Therefore, one of the aims of the present study is to identify these potential precursors through MALDI-IMS assays. This technique has enriched lipidomic studies due to the new dimensions added by IMS, i.e., the anatomical mapping of the molecules in tissue sections, a key piece of information to understand the physiological roles played by lipids present in the tissue ([@B10]; [@B30]; [@B61]; [@B47]).

Supporting the relationship between the eCB and LPA systems, it is relevant that the endogenous ligands for these systems are closely related, e.g., 2-AG can be metabolized to 2-arachidonoyl-LPA through the action of a monoacylglycerol kinase ([@B33]; [@B60]). The opposite direction of this phosphorylation reaction, i.e., dephosphorylation, also seems to be possible ([@B28]; [@B50]). Thus, it appears that 2-arachidonoyl-LPA and 2-AG could be mutually interconverted within a cell, and the direction of the reaction may even differ among the subcellular compartments within the cells and could be modified depending on the availability of substrates, such as ATP ([@B73]). However, 2-arachidonoyl LPA would not directly interact with the cannabinoid CB~1~ receptor, and 2-AG, in turn, would not display affinity for the LPA~1~ receptor ([@B50]). Moreover, structural analyses of the crystal structure of antagonist-bound LPA~1~ receptor predict a functional crosstalk with CB~1~ receptors ([@B13]).

During the last decade, the roles of the eCB and LPA systems in the regulation of neuronal progenitor proliferation and differentiation have been described, involving both systems in neurogenesis at the subventricular zone ([@B7]; [@B21]). However, LPA, through binding to the LPA~1~ receptor, acts only during the prenatal development of the brain ([@B26]). In the meantime, eCBs, through binding to CB~1~ and CB~2~ receptors, regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain ([@B53]). Nevertheless, the eCB system may also control embryonic neuronal development and maturation ([@B19]).

In addition, both systems display relevant roles in the limbic brain areas and pathways that control emotional processes, such as the amygdala connections, where both systems are involved in the extinction of fear-conditioned responses ([@B42]; [@B65]; [@B54]). Furthermore, both systems seem to be involved in the control of cognitive processes linked to the hippocampus, such as spatial memory. maLPA~1~-null mice showed, through the LPA~1~ receptor-signaling pathway, long-term spatial memory impairment, but not short-term memory impairment ([@B11]).

On the other hand, direct hippocampal CB~1~ activation by high doses of exogenous or endogenous cannabinoid compounds induce characteristic long-term memory impairment ([@B55]). In the same way, the genetic deletion of CB~1~ receptor induces neuronal loss in CA1 and CA3 areas of the hippocampus, which triggers a decline in cognitive functions ([@B6]).

In summary, both neurolipid systems are implicated in cortical development in the prenatal brain, in the extinction of fear-conditioned behavior in the amygdala, and in the modulation of long-term memory in the hippocampus, suggesting a convergence in the control of similar physiological functions in the CNS. In the present study we analyze the adaptive changes that are probably produced during mouse prenatal and postnatal development in the eCB and LPA neurolipid systems using both maLPA~1~-null and CB~1~ KO mice, to analyze the interactions and crosstalk between the CB~1~ and LPA~1~ mediated-activities and to identify the anatomical localization of the possible precursors of the endogenous ligands for both signaling systems. Technically, the study combines functional \[^35^S\]GTPγS autoradiography with MALDI-IMS to analyze consecutive brain slices.

Materials and Methods {#S2}
=====================

Chemicals {#S2.SS1}
---------

\[^35^S\]GTPγS (initial specific activity 1250 Ci/mmol) was purchased from Perkin Elmer (Boston, MA, United States). WIN55212-2 was purchased from Tocris (Bristol, United Kingdom). Oleoyl-L-α-lysophosphatidic acid sodium salt (LPA), 2-mercaptobenzothiazole (MBT), DL-dithiothreitol (DTT), guanosine-5′-diphosphate (GDP), guanosine-5′-o-3-triphosphate and β-radiation sensitive Kodak Biomax MR films were acquired from Sigma-Aldrich (St. Louis, MO, United States). The \[^14^C\]-microscales used as standards in the autoradiographic experiments were purchased from Amersham Biosciences (Buckinghamshire, United Kingdom) and American Radiolabeled Chemicals (ARC, St. Louis, MO, United States). Finally, for the preparation of the different buffers, the treatment of slides, re-crystallization of the matrix and film development, several additional compounds supplied from different laboratories were used. All the compounds were of the highest commercially available quality for the necessity of the neurochemical studies.

Animals and Tissue Preparation {#S2.SS2}
------------------------------

maLPA~1~-null homozygous (*n* = 8) and wild-type 3-month-old males (*n* = 8) (on a mixed background C57Bl/6 × 129SW) were obtained from Hospital Carlos Haya, Málaga, Spain, as a result of a collaboration with Dr. Estivill-Torrús's research group. The maLPA~1~-null (from Málaga variant of LPA~1~-null) mouse colony arose spontaneously from the initially reported LPA~1~-null mouse line ([@B15]) while crossing heterozygous foundational parents within their original mixed background since phenotypic variations have been described in almost complete perinatal viability and show a reduced VZ, altered neuronal markers, and increased cortical cell death that results in a loss of cortical layer cellularity in adults ([@B20]; [@B44]).

CB~1~-knockout mice are a strain maintained at the University of the Basque Country and were provided by C. Ledent of the University of Brussels (Belgium). For this study, 9 week-old male CB~1~-knockout (*n* = 5) and wild-type mice (*n* = 5) were used. The generation of mice lacking CB~1~ CBs was described previously ([@B36]). To homogenize the genetic background of the mice, the first generation of heterozygous mice was bred for 30 generations on a CD1 background, with selection for the mutant CB~1~ gene at each generation. Mice were housed in a temperature (22°C) and humidity-controlled (65%) room with a 12:12-h light/dark cycle (light between 08:00 and 20:00 h), with food and water *ad libitum*. All procedures were performed in accordance with European animal research laws (European Communities Council Directives 86/609/EEC, 98/81/CEE and 2003/65/CE; Commission Recommendation 2007/526/EC) and the Spanish National Guidelines for Animal Experimentation and the Use of Genetically Modified Organisms (Real Decreto 1205/2005 and 178/2004; Ley 32/2007 and 9/2003). All the experimental protocols were approved by the Local Ethics Committee for Animal Research at the University of the Basque Country (CEIAB/21/2010/Rodriguez Puertas).

Mouse brains were quickly removed under anesthesia. Then, tissues were frozen on dry ice and kept at −80°C. The brains were cut on a Microm HM550 cryostat (Thermo, Germany) to obtain 20 μm sections that were mounted onto gelatin-coated slides, and these were stored at −20°C until use.

\[^35^S\]GTPγS Binding Assay {#S2.SS3}
----------------------------

The tissue sections were air-dried for 15 min then washed in HEPES-based buffer (50 mM HEPES, 100 mM NaCl, 3 mM MgCl~2~, and 0.2 mM EGTA, pH 7.4) for 30 min at 30°C in a water bath. The preincubation was repeated in new buffer. In a second step, the slides were incubated for 2 h at 30°C supplemented with 2 mM GDP, 1 mM DTT, adenosine deaminase (3 μ/l) and 0.04 nM \[^35^S\]GTPγS. The agonist-stimulated binding was measured under the same conditions in the presence of the specific GPCR agonists oleoyl-L-α-lysophosphatidic acid sodium salt; LPA (10^--5^ M) and WIN55212-2 (10^--5^ M). Non-specific binding was determined in the presence of 10 μM non-labeled GTPγS. Sections were washed twice in an ice-cold (4°C) HEPES buffer (50 mM, pH 7.4), dipped in distilled water, and air-dried. Sections were exposed to autoradiography film (Kodak Biomax MR) together with ^14^C standards for 48 h at 4°C in hermetically closed cassettes.

Quantitative Image Analysis of Autoradiograms {#S2.SS4}
---------------------------------------------

Films were scanned and quantified by transforming the optical densities into nCi/g of tissue equivalent (nCi/g t.e.) using ImageJ software (NIH-IMAGE, Bethesda, MA, United States) (developed at the U.S. National Institutes of Health and freely available on <https://imagej.nih.gov/ij/>). The \[^14^C\] radioactive standards that were co-exposed with the tissue slides were used to calibrate the optical densities with the level of radioactivity labeled to the sections. Experimental data were analyzed by using the computer programs GraphPad Prism (v. 5.0, GraphPad) and Microsoft Excel. Data are expressed as the mean values ± SEM. The basal binding was calculated as nCi/g tissue equivalent, using the values provided in the ^14^C microscales. The agonist stimulation of \[^35^S\]GTPγS binding is expressed by the percentage of stimulation over the basal (%) in the presence of the different agonists, calculated as: ((\[^35^S\]GTPγS agonist-stimulated binding) × 100/(\[^35^S\]GTPγS basal binding)) − 100. The regions of interest (ROI) were defined from the scanned film in the case of the GTPγS autoradiography and directly from the image obtained from MALDI-IMS, using counter stained consecutive sections and a mouse brain atlas, without knowing the genotype of the mice and without taking into account the intensities of the rest of the animals. Differences between regions for each mouse genotype (wild type vs. transgenic) were analyzed by the unpaired two-tailed Student's *t* test.

Sample Preparation for MALDI-IMS {#S2.SS5}
--------------------------------

The original lipid composition and anatomical characteristics of the tissue must be well-preserved throughout the sample-preparation process ([@B59]). The fresh-frozen brains of the mice were cut on a Microm HM550 cryostat (Thermo, Germany) to obtain 20 μm sections and stored at −20°C until the moment of use.

Once the initial tissue preparation steps were completed, the matrix was deposited on the tissue surface prior to analysis by a sublimation process using the protocol described by [@B24]. For tissue sections mounted on glass slides, sublimation was performed using 300 mg of MBT, which was used as a chemical matrix, to control the deposition time and temperature (30 min, 140°C). Therefore, it was possible to control the thickness of the matrix layer and optimize the S/N ratio of the mass spectra, avoiding lipid migration on the tissue slice thanks to the lack of solvents using this sublimation procedure.

Mass Spectrometer {#S2.SS6}
-----------------

A MALDI LTQ-XL-Orbitrap (Thermo Fisher, San Jose, CA) equipped with a nitrogen laser (λ = 337 nm, rep. rate = 60 Hz, spot size = 80 × 120 μm) was used for mass analysis. Thermo's ImageQuest and Xcaliber software were used for MALDI-IMS data acquisition. The images were acquired in both negative and positive ion modes. The positive ion range was 500--1000 Da, with 10 laser shots per pixel at a laser fluence of 15 μJ. The negative ion range was 400--1100 Da, with 10 laser shots per pixel at a laser fluence of 15 μJ. The target plate stepping distance was set to 150 μm for both the *x*- and *y*-axes by the MSI image acquisition software. The mass resolution was approximately 100,000 laser shots in both positive and negative ion modes. The data were normalized using the TIC values to avoid potential displacement in the masses along the tissue that may be induced by experimental factors, including irregularities of the surface.

Image and Spectral Analysis for MALDI-IMS {#S2.SS7}
-----------------------------------------

The MALDI-IMS technique was applied to localize and semi-quantitatively analyze the different lipid species present in WT and maLPA~1~-null mice in positive and negative ion detection modes. We employed optimized experimental conditions for lipid detection previously set up by our research group and others, including selection of the MBT chemical matrix and deposition mode by sublimation procedures ([@B3]; [@B70]). First, IMS of sagittal mouse brain sections was performed using the positive ion detection mode, and approximately 300 mass peaks were detected in the mass range from 500 to 900 m/z. Then, the same slices of tissue were analyzed in negative ion detection mode using a mass range from 400 to 1100 m/z. A complete mass spectrum was obtained from each pixel along all the surface of each brain tissue slice, obtaining the slice images as a composition of the intensity color of each peak (molecule or m/z) at each pixel. Specifically, an ion of interest can be extracted from the spectra, and an image of that particular ion distribution in the tissue can be visualized. Once we had analyzed at least five sagittal brain slices samples from five different animals of  WT and another five samples of maLPA~1~-null mice, we selected different ROIs, such as hippocampus, cortex, cerebellum, cc, and striatum. The spectrum normalization was calculated using the TIC for each mass to exclude a number of noise spectra. Next, we compared WT and maLPA~1~-null using Origin^®^8 software.

In summary, the MALDI images were generated using ImageQuest software (Thermo Scientific). Each of the m/z values was plotted for signal intensity per pixel (mass spectrum) across a given area (tissue section). The m/z range of interest was normalized using the ratio of the TIC for each mass spectrum. The intensity reached by each mass spectrum (intensity of each peak, m/z value or molecule) was further calculated as a ratio of the peak with the highest intensity, and the average spectrum was calculated with OriginPro 8 software (Northampton, MA, United States). The most intense peak was considered 100%. Then, the two-tailed unpaired *t* test was performed for the comparison of two groups. The results were considered significant if *p* ≤ 0.05.

Peak Assignment {#S2.SS8}
---------------

Analysis of the lipid composition at CNS tissue samples from mice included in the present study was complex. A large number of different possible lipid species were detected, and some of them shared similar masses and were not detected and/or assigned to a specific lipid molecule by previous studies. Nevertheless, the assignment of lipid species was facilitated by the use of the Lipid MAPS database^[1](#footnote1){ref-type="fn"}^ and different previous reports ([@B5]; [@B43]), using a 5 ppm mass accuracy as the tolerance window for the assignment. The numbers (x:y) following the glycerolipid species denote the total length and the number of double bonds of the acyl chains, respectively, while the GlcCer species numbers correspond to the length and number of double bonds of the acyl chain added to those of the attached sphing-4-enine (d18:1) or sphinganine (d18:0) base.

Results {#S3}
=======

\[^35^S\]GTPγS Binding Assay of maLPA~1~-Null Mouse Brain Sections {#S3.SS1}
------------------------------------------------------------------

The \[^35^S\]GTPγS binding stimulated by WIN55212-2 was measured in brain slices of maLPA~1~-null and WT mice to localize and quantify the activity of CB~1~ CBs. The aim was to observe, in adult mice was the possible modulation of cannabinoid signaling that was induced by the lack of the LPA receptor subtype, LPA~1~, during the animal's previous development. The basal activity (in the absence of agonist) of the G~i/o~-coupled GPCR in maLPA~1~-null mice was already shown in [@B23]. The G~i/o~-coupled CB~1~ receptor activity induced by the CB~1~ agonist WIN55212-2 was increased at the prefrontal cortex layers I--III (WT 212 ± 19% vs. maLPA~1~-null 369 ± 49%, *p* ≤ 0.05) and in layer VI (WT 284 ± 14% vs. maLPA~1~-null 396 ± 22%, *p* ≤ 0.05). The increase in the CB~1~ activity was also significant in the cerebellum gray matter (cb GM) of maLPA~1~-null mice compared to WT (WT 23 ± 15% vs. maLPA~1~-null 107 ± 13%, *p* ≤ 0.05) and cb WM (WT 678 ± 149% vs. maLPA~1~-null 1377 ± 207%, *p* ≤ 0.05). The globus pallidus, a nucleus with a high density of CB~1~ receptors in mice, also showed an increase in the activity of these receptors in maLPA~1~-null mice (WT 1705 ± 151% vs. maLPA~1~-null 2037 ± 82%), but this change was not statistically significant ([Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). The \[^35^S\]GTPγS binding stimulated by oleoyl-L-α-lysophosphatidic acid sodium salt (LPA) showed no stimulations in any brain area of the maLPA~1~-null mice, demonstrating the specificity of the experimental binding procedure and the right phenotype of the animals ([@B23]).

###### 

\[^35^S\]GTPγS binding induced by WIN55212-2 (10 μM) in different areas of WT and maLPA~1~-null mice, calculated as percentage over the basal value.

                        **Stimulation by WIN55212-2 (%)**                
  --------------------- ----------------------------------- ------------ -------
  Amygdala              36250                               23222        0.06
  **Cerebellum**                                                         
  White matter          2.315                               10713^∗^     0.001
  Gray matter           679149                              1377207^∗^   0.04
  Corpus callosum       10820                               15011        0.18
  Striatum              25418                               25523        0.75
  **Frontal cortex**                                                     
  Layer I--III          21219                               36949^∗^     0.05
  Layer IV              18833                               23614        0.27
  Layer V               22325                               28212        0.07
  Layer VI              28414                               39622^∗^     0.02
  **Hippocampus**                                                        
  Dorsal CA1 radiata    37151                               34138        0.69
  Ventral CA3 radiata   28823                               26612        0.51
  Internal capsule      5316                                3314         0.28
  Globus pallidus       1705151                             203782       0.21

Data are mean ± SEM values, in percentage of stimulation over the basal (%). The
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![Representative autoradiograms of WT **(A)** and maLPA~1~-null mice **(B)** in sagittal sections that show \[^35^S\]GTPγS binding stimulated by WIN55212-2 (10^--\ 5^ M). Note the increase in the binding in maLPA~1~-null mice at different cortical layers (Layer I--III and Layer VI) and at the cerebellar gray matter (cb GM) and white matter (cb WM). Scale bar = 3 mm.](fnmol-12-00223-g001){#F1}

\[^35^S\]GTPγS Binding Assay in CB~1~ KO Mouse Brain Sections {#S3.SS2}
-------------------------------------------------------------

We compared the \[^35^S\]GTPγS binding stimulated by LPA in CB~1~ KO and WT mice to observe the consequences of the developmental absence of the main eCB receptor on the signaling through cerebral GPCRs for the LPA~1~ receptors. There were statistically significant changes that were restricted to the amygdala and showed increased \[^35^S\]GTPγS binding induced by LPA (WT −20 ± 4.3% vs. CB~1~ KO 32 ± 6.3%, *p* ≤ 0.05). The LPA~1~ receptor activity of CB~1~ KO mice was comparable to WT mice in all the other brain areas that were analyzed ([Table 2](#T2){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). The \[^35^S\]GTPγS binding stimulated by WIN55212-2 showed no stimulation in any brain area of the CB~1~ KO mice, demonstrating the specificity of the experimental binding procedure and the right phenotype of the animals (data not shown).

###### 

\[^35^S\]GTPγS binding induced by LPA (10 μM) in different areas of WT and CB~1~ KO mouse brains, calculated as stimulation percentage over basal.

                        **Stimulation by LPA (%)**              
  --------------------- ---------------------------- ---------- --------
  Amygdala              −204.3                       326.3^∗^   0.0008
  **Cerebellum**                                                
  White matter          22956                        12446      0.2
  Gray matter           506.5                        5127       0.96
  Corpus callosum       34372                        32559      0.84
  Striatum              219.3                        245.5      0.8
  **Frontal cortex**                                            
  Layer I--III          6019                         4621       0.6
  Layer IV              5314                         5727       0.62
  Layer V               5011                         6426       0.64
  Layer VI              4815                         6228       0.57
  **Hippocampus**                                               
  Dorsal CA1 radiata    4211                         1823       0.38
  Ventral CA3 radiata   1.413                        145        0.44
  Internal capsule      20341                        21044      0.91
  Globus pallidus       2.211                        6242       0.16

Data are mean ± SEM values, in percentage of stimulation over basal (%). SEM values, in percentage of stimulation over basal (%). The

p-

values were calculated by the unpaired two-tailed Student's

t

test.
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![Autoradiographic images of sagittal sections from WT **(A)** and CB~1~ KO mice **(B)** showing \[^35^S\]GTPγS binding stimulated by LPA (10^--\ 5^ M). Note the increase in the binding at the amygdala in CB~1~ KO mice. Scale bar = 3 mm.](fnmol-12-00223-g002){#F2}

MALDI-IMS in maLPA~1~-Null Mouse Brain Sections {#S3.SS3}
-----------------------------------------------

Some lipid species showed changes in positive ion detection mode in maLPA~1~-null mice compared to WT mice. Three lipid species, GlcCer (d18:1/14:0) + K^+^ in cortex (WT 14.5 ± 0.8% vs. maLPA~1~-null 9.3 ± 1.5%, *p* \< 0.05) and striatum (WT 22.0 ± 1.3% vs. maLPA~1~-null 15.2 ± 2.3%, *p* ≤ 0.05), PA (16:0/18:1) + K^+^ in hippocampus (WT 46.5 ± 2.0% vs. maLPA~1~-null 37.2 ± 3.4%, not significant) and cortex (WT 47.5 ± 2.0% vs. maLPA~1~-null 37.3 ± 3.5%, *p* ≤ 0.05), and PC(32:0)^+^ in hippocampus (WT 27.3 ± 3.6% vs. maLPA~1~-null 17.9 ± 0.5%, *p* ≤ 0.05), were present at lower levels in maLPA~1~-null mice. By contrast, the intensity of the peaks for PC(36:1) + K^+^ in hippocampus (WT 16.3 ± 0.8% vs. maLPA~1~-null 20.4 ± 0.5%, *p* \< 0.05) and cortex (WT 15.8 ± 0.7% vs. maLPA~1~-null 19.6 ± 1.5%, *p* ≤ 0.05), PC(38:4) + K^+^ in hippocampus (WT 8.4 ± 0.4% vs. maLPA~1~-null 11.3 ± 1.0%, *p* ≤ 0.05) and cortex (WT 10.3 ± 0.7% vs. maLPA~1~-null 13.5 ± 1.1%, *p* ≤ 0.05) and PC(38:6) + K^+^ in hippocampus (WT 12.0 ± 0.6% vs. maLPA~1~-null 15.7 ± 0.9%, *p* ≤ 0.05) was higher in the KO mice ([Table 3](#T3){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}. See "*p*" values in table of [Supplementary  Material](#SM1){ref-type="supplementary-material"}).

###### 

MALDI-IMS intensities (expressed as % of the most abundant peak) of molecular species of PC and PA that were found modified in positive ion detection mode in sagittal brain sections from WT (*n* = 5) compared to the maLPA~1~-null (*n* = 5).

                                                 **Cortex**   **Hippocampus**   **Striatum**   **Corpus callosum**   **Cerebellum**                                                          
  ------------------------------- -------------- ------------ ----------------- -------------- --------------------- ---------------- --------------- ------------ ------------ ------------ ---------------
  **GlcCer(d18:1/14:0) + K^+^**   **710.4899**   14.5 ± 0.8   9.3 ± 1.5^∗∗^     22.6 ± 1.0     19.1 ± 2.4            22.0 ± 1.3       15.2 ± 2.3^∗^   14 ± 0.9     11.1 ± 1.7   21.3 ± 2.3   21.1 ± 3.5
  **PA(16:0/18:1) + K^+^**        **713.4535**   47.6 ± 2.0   37.3 ± 3.5^∗^     46.5 ± 2.0     37.2 ± 3.4^∗^         45.1 ± 2.2       35.3 ± 3.3^∗^   34.6 ± 2.9   28.9 ± 2.9   34.5 ± 1.1   32.2 ± 4.3
  **PC(32:0)^+^**                 **734.5700**   20.2 ± 3.2   25.3 ± 7.1        27.1 ± 3.6     17.9 ± 1.7^∗^         28.1 ± 3.3       26.7 ± 6.1      19.5 ± 3.0   20.9 ± 4.3   21.4 ± 2.2   22.7 ± 4.4
  **PC(36:1) + K^+^**             **826.5733**   15.8 ± 0.7   19.6 ± 1.5^∗^     16.3 ± 0.8     20.4 ± 0.5^∗^         22.2 ± 1         26.2 ± 0.9^∗^   37.7 ± 1.1   42.0 ± 3.6   28.1 ± 0.8   28.2 ± 0.9
  **PC(38:6) + K^+^**             **844.5270**   10.3 ± 0.7   13.5 ± 1.1^∗^     8.4 ± 0.4      11.3 ± 1.0^∗^         8.3 ± 0.6        10.3 ± 1.2      6.5 ± 0.5    8.5 ± 1.6    12.9 ± 1.1   16.1 ± 0.6^∗^
  **PC(38:4) + K^+^**             **848.5572**   8.1 ± 0.9    8.7 ± 1.1         12 ± 0.6       15.7 ± 0.9^∗^         11.1 ± 0.6       13.2 ± 1.0      8.9 ± 0.4    11.1 ± 1.1   5.3 ± 0.2    6.4 ± 0.4^∗^

Data are mean ± SEM values. The

p-

values were calculated by the unpaired two-tailed Student's

t

test
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![MALDI-IMS images representing different lipid species that showed statistically significant differences in the detection intensities between WT and maLPA~1~-null mice. The color images were obtained following the IMS conditions of 150 μm of spatial resolution, 10 shots per pixel at laser fluence of 15 μJ. The intensity of each lipid species is represented on the color scale, shown on the right side, as a ratio of the most abundant signal.](fnmol-12-00223-g003){#F3}

MALDI-IMS in CB~1~ KO Mouse Brain Sections {#S3.SS4}
------------------------------------------

The results of the MALDI-IMS experiments using CNS slices from WT and CB~1~ KO mice were also performed in positive and negative ion detection modes. As has been described, we used an optimized protocol for the lipid detection. The analysis of IMS on sagittal mouse brain slices was performed in positive ion detection mode in a mass range from 500 to 1000 m/z and in negative ion detection mode from 400 to 1100 m/z. We selected the ROI and followed the steps described in the "Materials and Methods" section. The results indicated that some lipid species were modified in the brain of CB~1~ KO mice in both positive and negative ion detection modes. Some lipid species were present at a higher intensity than in WT mouse brain. These lipid species included PC(32:0)^+^ in hippocampus (WT 37.6 ± 3.6% vs. CB~1~ KO 65.3 ± 3.1%, *p* \< 0.01) and cortex (WT 33.2 ± 3.7% vs. CB~1~ KO 54.7 ± 6.5%, *p* \< 0.05) and PC(34:1)^+^ also in hippocampus (WT 48.6 ± 5.0% vs. CB~1~ KO 67.7 ± 3.5%, *p* \< 0.05) and cortex (WT 51.2 ± 4.8% vs. CB~1~ KO 69.5 ± 4.5%, *p* \< 0.05). Both PC molecules were increased in the frontal cortex, hippocampus and striatum but were not modified in the cerebellum of the CB~1~ KO mice. In contrast, the relative intensities of other lipid species were lower in CB~1~ KO mice than in WT mice in the hippocampus, frontal cortex and cerebellum but not modified in the striatum. These lipid species included PE(p18:0/22:6) in hippocampus (WT 3.4 ± 0.2% vs. CB~1~ KO 1.1 ± 0.6%, *p* \< 0.05) and cortex (WT 3.7 ± 0.1% vs. CB~1~ KO 1.0 ± 0.6%, *p* \< 0.05), PE(18:0/22:6)^--^ in hippocampus (WT 8.5 ± 0.3% vs. CB~1~ KO 4.4 ± 1.9%, *p* \< 0.01), and phosphatidylserine (PS) (18:0/22:6)^--^ in cortex (WT 73.3 ± 9.5% vs. CB~1~ KO 46.9 ± 4.7%, *p* \< 0.01) and striatum (WT 57.9 ± 4.8% vs. CB~1~ KO 40 ± 2.7%, *p* \< 0.05) ([Table 4](#T4){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}. See "*p*" values in table of [Supplementary  Material](#SM1){ref-type="supplementary-material"}).

###### 

MALDI-IMS intensities (expressed as % of the most abundant peak) of molecular species of PC, PE, and PS in positive and negative ion detection modes that were modified in sagittal brain sections from WT (*n* = 5) compared to CB~1~ KO mice (*n* = 5).

                                          **Cortex**   **Hippocampus**   **Striatum**   **Cerebellum**                                    
  ------------------------ -------------- ------------ ----------------- -------------- ---------------- --------- ------------ --------- -----------
  **PC(32:0)^+^**          **736.5654**   33.23.7      54.76.5^∗^        37.63.6        65.43.1^∗∗^      31.44.1   49.36^∗^     42.37.5   51.44
  **PC(34:1)^+^**          **760.5856**   51.24.8      69.54.5^∗^        48.65.0        67.73.5^∗^       51.75.2   67.75.1^∗^   65.27.9   72.34.2
  **PE(p18:0/22:6)^--^**   **774.5432**   3.70.1       10.6^∗∗^          3.40.2         1.10.6^∗^        1.40.2    0.90.2       4.11.2    1.50.5
  **PE(18:0/22:6)^--^**    **790.5381**   12.60.7      102.9             8.50.3         4.41.9^∗∗^       9.51.2    60.9         10.62     5.60.9^∗^
  **PS(18:0/22:6)^--^**    **834.5252**   73.39.5      46.94.7^∗∗^       53.94.5        44.94.3          57.94.8   402.7^∗^     41.17.7   32.62.4

Data are mean ± SEM values. The

p

-values were calculated by the unpaired two-tailed Student's

t

test

∗

p

≤ 0.05,

∗∗

p

≤ 0.01.

![MALDI-IMS images representing the different lipid species that showed statistically significant differences in the detection intensities between WT and CB~1~ KO mice. The spectra were recorded with 150 μm spacing. Ten shots at each point were accumulated. Laser fluency was set at 15 μJ.](fnmol-12-00223-g004){#F4}

Discussion {#S4}
==========

The present study shows specific anatomical alterations of a few lipid species that are potential PL precursors of LPA or eCBs, analyzing simultaneously in the same animals the regulation of the signaling by their specific CB~1~ and LPA~1~ receptors in KO mice for each of these receptors, which are the respective predominant subtypes present in the CNS. The analyzed regions were selected attending to previously described brain areas showing high densities of LPA~1~ or CB~1~ receptors.

The analysis of the activity of CB~1~ receptors in maLPA~1~-null mice allowed us to detect a regulation mechanism in both in the frontal cortex and in the cerebellum. The absence of LPA~1~ in maLPA~1~-null mice results in a reduction of neural cells in layers II/III, V, and VI, increased apoptosis, alterations in the formation of the cerebral cortex and premature expression of neuronal markers ([@B20]). The eCB system is a critical component of frontal cortex physiology. The CB~1~ receptor is mainly expressed in layers II/III and V/VI ([@B34]), same areas where there is a depletion of neurons in maLPA~1~-null mice. Therefore, the increased functional activity of CB~1~ receptors suggests a compensatory effect of the eCB system to balance the neuronal reduction. Furthermore, the cerebellum is another brain area where we detected an increase in CB~1~ receptor activity in maLPA~1~-null mice. Cannabinoids modulate the proliferation of cerebellar neuronal precursors via the CB~1~ receptor ([@B66]). Hence, the lack of the LPA~1~ receptor could lead to an adaptive regulation in CB~1~-mediated activity.

On the other hand, when the activity of LPA~1~ receptors was analyzed in CB~1~ KO mice, the LPA~1~ receptor activity was increased only in the amygdala compared with WT mice. The CB~1~ receptor plays an important role in processes mediated by the amygdala, such as emotional responses ([@B4]; [@B35]; [@B56]; [@B65]). The eCB system in the amygdala has also been implicated in pain modulation ([@B41]), fear conditioning ([@B42]), anxiety ([@B29]) and fear-conditioned learning ([@B37]). The LPA~1~ receptor plays a crucial role in the extinction of fear conditioning ([@B54]) and has been associated with the mixed depressive-anxiety phenotype ([@B48]). Our results suggest that the lack of the CB~1~ receptor leads to an increased LPA~1~ receptor activity in the amygdala, as a compensatory effect exerted by LPA signaling in this limbic area. Considering the present results, it is difficult to hypothesize why no other brain regions have been regulated in CB~1~ KO mice, this regional exclusivity to the amygdala emphasizes the already reported role of LPA~1~ receptors in fear extinction, that might be indicating a close physiological control in anxiety behavior and fear-conditioned learning together with CB~1~ receptors. However, other functions modulated by the eCB system, such as pain or movement control, are possibly not being compensated by LPA~1~ signaling.

The lack of LPA~1~ receptor expression during mouse development led to an increase in the activity of the CB~1~ receptor in the cortical area and cerebellum, and the lack of the CB~1~ receptor led to an increase in LPA~1~ receptor activity in the amygdala. Therefore, the absence of neurotransmissions mediated by CB~1~ or LPA~1~ receptors in each strain of knockout mice converged to a common compensatory mechanism between both systems in some specific brain areas (cortex, cerebellum and amygdala). The reported compensation would affect receptors coupled to other types of G proteins, however, as previously mentioned, we were only able to analyze those coupled to the G~*i/o*~ subtype. It is improbable that CB~1~ receptors play a role since previous results reported a similar distribution regarding the CB~1~ receptor autoradiographic densities compared to functional autoradiography stimulated by specific agonists such as the WIN55212-2 ([@B38]). However, it has not been yet possible to get the distribution of LPA~1~ receptors.

Moreover, the co-regulation of eCBs and LPA must be yielded during the pre- and postnatal development of both strains of mice.

The mechanisms underlying the observed modulation of CB~1~ receptors in LPA~1~-null mice may involve an increase in the expression of CB~1~ receptors mediated by another subtype of LPA receptors coupled to G~*i/o*~ proteins (see [Supplementary  Material](#SM1){ref-type="supplementary-material"}).

The metabolic precursors of the endogenous agonists for both neurolipid systems, eCB and LPA, are PLs present at the cellular membranes. The metabolism of PLs such as PC, PS and PE is thought to be responsible for the synthesis of LPA and the eCBs AEA and 2-AG. Therefore, we also hypothesized that the identification of specific PL modifications in the brain of CB~1~- and LPA~1~-KO mice would help us to understand the molecular neuroscience of the interactions between both systems. Thus, the PL precursor localization was an important step to clarify the synthesis of these lipid mediators. The application of the MALDI-IMS technique to maLPA~1~-null and CB~1~ KO mice allowed us to determine the anatomical localization of each lipid species in brain tissue slices. Unlike classical neurotransmitters, eCBs and LPA are not stored in specific compartments of the cells, such as vesicles, but instead are produced mainly "on demand" by stimulus-dependent cleavage of membrane PL precursors ([@B57]; [@B18]; [@B62]; [@B1]). However, little is known about which are the specific lipid species for the synthesis of the endogenous agonists LPA, AEA, and 2-AG, or about their anatomical localization within the brain.

The results obtained with the MALDI-IMS assay in maLPA~1~-null and WT mice showed differences in the intensity of some lipid species, mainly in the positive ion detection mode. The affected species were PA(16:0/18:1) + K^+^ and four different PCs, including PC(32:0), PC(36:1) + K^+^, PC(38:6) + K^+^, and PC(38:4) + K^+^, whose more probable acyl chains were assigned based on previous studies and were identified as 16:0, 18:0, 18:1, 20:4, and 22:6 ([@B64]; [@B5]; [@B43]). Although much has been learned about the physiological roles of LPA through the analyses of LPA receptors, the mechanism by which LPA is produced remains unclear. At least two pathways have been postulated. In the first pathway, LPA would be produced from PL by the autotaxin enzyme. In the second pathway, PA would be generated from PL or diacylglycerol and then deacylated by different phospholipases, such as PLA~1~ or PLA~2~ ([@B1]; [@B2]). The predominant fatty acyl moieties identified for LPA in rat brain are 18:1 (46.9%), 18:0 (22.5%), and 16:0 (18.8%), although a relatively small, but significant, amount of a 20:4-containing species has also been detected (7.2%) ([@B16]; [@B63]). PC species with arachidonic acid as its acyl chain PC(38:4), which was significantly increased in maLPA~1~-null mice in the cerebellum, could be a precursor of LPA (20:4). This species could be converted to 2-AG through LPA-phosphatase and trigger the increase in CB~1~ receptor activity ([@B50]). Moreover, PC(36:1) is significantly increased in most of the analyzed areas and tended to increase in the maLPA~1~-null mice in brain areas where LPA~1~ receptors are specifically distributed, suggesting that PC(36:1) is a potential precursor for LPA synthesis ([@B23]; [@B46]).

Regarding the MALDI-IMS results in CB~1~ KO and corresponding WT mice, the ratio of some lipid species was changed compared to WT mice, in both positive and negative ion detection modes. The affected species were PCs, PEs and PSs. PC(32:0) and PC(34:1) were increased approximately 50% in CB~1~ KO mice in some areas, such as the hippocampus and frontal cortex. We assumed that changes in PC(32:0) and PC(34:1) indicated that the lack of the CB~1~ receptor led to an increase in the abundance of lipids with palmitic acid. Both PCs can contain palmitic acid at fatty acyl moieties, and the CB~1~ receptor is palmitoylated for efficient coupling to a specific subset of G proteins located on membrane lipid rafts with a high concentration of saturated fatty acids ([@B52]).

The synthesis of AEA and 2-AG could be produced by the cleavage or hydrolysis of membrane PL precursors. For the synthesis of 2-AG, at least three pathways have been proposed ([@B27]; [@B50]; [@B32]). The synthesis of AEA seems to involve the enzymatic hydrolysis of the corresponding *N*-acyl-phosphatidylethanolamines (NAPE) (reviewed in [@B57], [@B58]; [@B25]). In view of our results, we infer that the observed decrease in PE species in CB~1~ KO compared with WT mice could be related to precursors of AEA, due to the requirement of PE molecules for AEA synthesis. This decrease may be a modulation of PEs due to the lack of the target, the CB~1~ receptor. In addition, the decrease in PS species could be derived from the PE diminution because PE is one of the sources for PS synthesis ([@B68]). However, no changes in AEA or 2-AG levels have been reported between CB~1~ KO and WT mice ([@B40]). The undergoing neuro-adaptive metabolic changes could lead to an increase in the activity of the enzymes responsible for the production of AEA from PE in KO mice, but obtaining the same levels of AEA than in WT.

Globally, the absence of LPA~1~ or CB~1~ receptors is able to induce modulation on the other system at the levels of both signaling and synthesis of endogenous neurotransmitters, suggesting adaptive responses between both systems during prenatal and/or postnatal development. Future goals would be to further clarify the relationship between the cannabinoid and lysophosphatidic systems as neurolipid systems with potential neuroprotective actions to identify new therapeutic treatments that could be developed for neurodegenerative diseases, such as Alzheimer's disease.
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2-AG

:   2-araquidonoil glycerol

AEA

:   anandamide

cb WM

:   cerebellum white matter

CB

:   cannabinoid receptor

cc

:   corpus callosum

Cx layer VI

:   frontal cortex layer VI

eCB

:   endocannabinoid

GlcCer

:   glucosylceramide

GPCR

:   G protein-coupled receptor

ic

:   internal capsule

LP

:   lysophospholipid

LPA

:   lysophosphatidic acid

MALDI-IMS

:   matrix-assisted laser desorption/ionization imaging mass spectrometry

PA

:   phosphatidic acid

PC

:   phosphatidylcholine

PE

:   phosphatidylethanolamine

ROI

:   region of interest

TIC

:   total ion current

VZ

:   ventricular zone.
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